1. Corina Corina United States says:

    I'm eager to see the final results of this research. Hopefully, this vaccine is as effective as the Gardasil vaccine that protects women against certain strains of HPV. Herpes is rapidly growing and many studies suggest that by 2025 49% of women between ages 15 and 39 will have acquired HSV2. Also, by 2025 it's estimated that 39% of men will have HSV2. There is a huge herpes market and an excellent source of profit. Millions of people will be willing to take the prophylactic vaccine and millions more will be more than excited to have a therapeutic vaccine to protect others from contracting this virus. Also, a therapeutic vaccine that drastically decreases outbreaks and viral shedding is worth a million bucks for us who suffer from this horrible virus.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.